New Century Healthcare Completes HKEX-Mandated Internal Control Review and Director Training

New Century Healthcare Holding Co. Ltd. ( (HK:1518) ) has issued an update.

New Century Healthcare Holding Co. Ltd. has completed an internal control review and director training mandated by the Hong Kong Stock Exchange following disciplinary action related to compliance with Listing Rules on notifiable and connected transactions. The company engaged Acclime Consulting (Hong Kong) Limited to assess and enhance its internal controls over the identification, authorization, record-keeping, reporting and disclosure of such transactions, as well as internal training and segregation of duties, covering the period from July 2024 to June 2025 with follow-up through September 2025. The review identified deficiencies and led to recommendations and implementation measures, including optimization of management policies on connected transactions, while the relevant directors have fulfilled prescribed hours of regulatory, legal and corporate governance training, which is expected to strengthen the Group’s governance framework and regulatory compliance.

The most recent analyst rating on (HK:1518) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on New Century Healthcare Holding Co. Ltd. stock, see the HK:1518 Stock Forecast page.

More about New Century Healthcare Holding Co. Ltd.

New Century Healthcare Holding Co. Ltd. is a Hong Kong-listed company incorporated in the Cayman Islands, operating through a group structure and subject to Hong Kong Listing Rules, particularly concerning notifiable and connected transactions under Chapters 14 and 14A.

Average Trading Volume: 280,235

Technical Sentiment Signal: Sell

Current Market Cap: HK$341.7M

See more insights into 1518 stock on TipRanks’ Stock Analysis page.